ReP USP - Resultado da busca

Artigo de periodico
Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations (2024)
Ponnaiah, Maharajah; Zakiev, Emile; Lhomme, Marie; Rached, Fabiana; Camont, Laurent; Serrano Junior, Carlos Vicente ; Santos Filho, Raul Dias dos ; Chapman, M. John; Orekhov, Alexander; Kontush, Anatol
Source: ATHEROSCLEROSIS PLUS. Unidade: FM
Subjects: LIPOPROTEÍNAS LDL, INFARTO DO MIOCÁRDIO, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONNAIAH, Maharajah et al. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, v. 55, p. 21-30, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/58815. Acesso em: 16 nov. 2024.
APA
Ponnaiah, M., Zakiev, E., Lhomme, M., Rached, F., Camont, L., Serrano Junior, C. V., et al. (2024). Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations. ATHEROSCLEROSIS PLUS, 55, 21-30. doi:10.1016/j.athplu.2023.12.001
NLM
Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
Vancouver
Ponnaiah M, Zakiev E, Lhomme M, Rached F, Camont L, Serrano Junior CV, Santos Filho RD dos, Chapman MJ, Orekhov A, Kontush A. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations [Internet]. ATHEROSCLEROSIS PLUS. 2024 ; 55 21-30.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/58815
Artigo de periodico
Management of cardiogenic shock complicating myocardial infarction (2018)
Mebazaa, Alexandre; Hajjar, Ludhmila Abrahao
Source: Intensive care medicine. Unidade: FM
Subjects: CHOQUE CARDIOGÊNICO, ESTUDOS RANDOMIZADOS, CUIDADOS CRÍTICOS, ANGIOPLASTIA TRANSLUMINAL PERCUTÂNEA CORONÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEBAZAA, Alexandre e HAJJAR, Ludhmila Abrahao. Management of cardiogenic shock complicating myocardial infarction. Intensive care medicine, v. 44, n. 6, p. 760-773, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00134-018-5214-9. Acesso em: 16 nov. 2024.
APA
Mebazaa, A., & Hajjar, L. A. (2018). Management of cardiogenic shock complicating myocardial infarction. Intensive care medicine, 44( 6), 760-773. doi:10.1007/s00134-018-5214-9
NLM
Mebazaa A, Hajjar LA. Management of cardiogenic shock complicating myocardial infarction [Internet]. Intensive care medicine. 2018 ; 44( 6): 760-773.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00134-018-5214-9
Vancouver
Mebazaa A, Hajjar LA. Management of cardiogenic shock complicating myocardial infarction [Internet]. Intensive care medicine. 2018 ; 44( 6): 760-773.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00134-018-5214-9
Artigo de periodico
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) (2018)
Giugliano, Robert P.; Nicolau, Jose Carlos
Source: Circulation. Unidade: FM
Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIUGLIANO, Robert P. e NICOLAU, Jose Carlos. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, v. 137, n. 15, p. 1571-0, 2018Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.117.030950. Acesso em: 16 nov. 2024.
APA
Giugliano, R. P., & Nicolau, J. C. (2018). Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). Circulation, 137( 15), 1571-0. doi:10.1161/CIRCULATIONAHA.117.030950
NLM
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Vancouver
Giugliano RP, Nicolau JC. Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) [Internet]. Circulation. 2018 ; 137( 15): 1571-0.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.117.030950
Artigo de periodico
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD (2017)
Charytan, David M.; Burdmann, Emmanuel de Almeida
Source: American journal of kidney diseases. Unidade: FM
Subjects: FALÊNCIA RENAL CRÔNICA, DOENÇAS CARDIOVASCULARES, DIABETES MELLITUS, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHARYTAN, David M. e BURDMANN, Emmanuel de Almeida. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, v. 70, n. 4, p. 522-531, 2017Tradução . . Disponível em: http://observatorio.fm.usp.br/handle/OPI/21785. Acesso em: 16 nov. 2024.
APA
Charytan, D. M., & Burdmann, E. de A. (2017). ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD. American journal of kidney diseases, 70( 4), 522-531. doi:10.1053/j.ajkd.2017.04.018
NLM
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2024 nov. 16 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785
Vancouver
Charytan DM, Burdmann E de A. ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD [Internet]. American journal of kidney diseases. 2017 ; 70( 4): 522-531.[citado 2024 nov. 16 ] Available from: http://observatorio.fm.usp.br/handle/OPI/21785

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies